Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer

Tasuku Matsuoka,Masakazu Yashiro

DOI: https://doi.org/10.3390/ijms25115880

IF: 5.6

2024-05-29

International Journal of Molecular Sciences

Abstract:Gastric cancer (GC) is one of the most common cancers worldwide. Most patients are diagnosed at the progressive stage of the disease, and current anticancer drug advancements are still lacking. Therefore, it is crucial to find relevant biomarkers with the accurate prediction of prognoses and good predictive accuracy to select appropriate patients with GC. Recent advances in molecular profiling technologies, including genomics, epigenomics, transcriptomics, proteomics, and metabolomics, have enabled the approach of GC biology at multiple levels of omics interaction networks. Systemic biological analyses, such as computational inference of "big data" and advanced bioinformatic approaches, are emerging to identify the key molecular biomarkers of GC, which would benefit targeted therapies. This review summarizes the current status of how bioinformatics analysis contributes to biomarker discovery for prognosis and prediction of therapeutic efficacy in GC based on a search of the medical literature. We highlight emerging individual multi-omics datasets, such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics, for validating putative markers. Finally, we discuss the current challenges and future perspectives to integrate multi-omics analysis for improving biomarker implementation. The practical integration of bioinformatics analysis and multi-omics datasets under complementary computational analysis is having a great impact on the search for predictive and prognostic biomarkers and may lead to an important revolution in treatment.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper attempts to address the issue of discovering and validating predictive and prognostic biomarkers for gastric cancer (GC). Specifically, the authors aim to identify biomarkers related to the prediction of treatment outcomes and prognosis in gastric cancer patients through comprehensive bioinformatics analysis and multi-omics data. The current five-year survival rate for gastric cancer patients remains low, primarily due to the lack of effective treatment methods. Therefore, finding relevant biomarkers with high predictive accuracy to select gastric cancer patients who may benefit from targeted therapy is crucial. The paper reviews how bioinformatics analysis can be utilized to discover biomarkers in the prognosis and treatment outcome prediction of gastric cancer and emphasizes the role of multi-omics datasets, including genomics, epigenomics, transcriptomics, proteomics, and metabolomics, in validating potential biomarkers. Finally, it discusses the current challenges and future prospects of integrating multi-omics analysis to improve the clinical application of biomarkers.